These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23559676)

  • 21. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment.
    Lye WC; Lee EJ
    Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial.
    Santos F; Moreno ML; Neto A; Ariceta G; Vara J; Alonso A; Bueno A; Afonso AC; Correia AJ; Muley R; Barrios V; Gómez C; Argente J
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1190-7. PubMed ID: 20522533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
    Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
    Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
    De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
    Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F; Ince E; Tümer N; Ensari A; Ozkaya N
    Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
    Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
    Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal administration of recombinant human growth hormone in children with end-stage renal disease.
    Gipson DS; Kausz AT; Striegel JE; Melvin TR; Astrom LJ; Watkins SL
    Pediatr Nephrol; 2001 Jan; 16(1):29-34. PubMed ID: 11198599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies.
    Kandemir N; Gonc EN; Yordam N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):809-16. PubMed ID: 12099391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
    Ziółkowska H; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
    Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
    J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
    Piscitelli J; Cabansag MR; Silverstein DM
    J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.
    Fehmi H; Osman Y; Bhat S; Nguyen K; Daramola O; Cantor T; Monier-Faugere MC; Yee J; Malluche HH
    Clin Nephrol; 2009 Mar; 71(3):267-75. PubMed ID: 19281737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.